Aim To explore breast cancer patient's perspective on future genetic testing for prediction of
toxicity after breast radiotherapy (RT). Materials and methods The study involved patient …

Methods: From April 2001, 284 breast cancer patients, who underwent radiotherapy with
breast-con-serving surgery, were enrolled from 4 collaborating institutions in Japan. We …

Background. Individual radiosensitivity has a crucial impact on radiotherapy related side
effects. Our aim was to study a breast cancer collective for its variation of individual …

A recent paper has addressed the impact associated with addition of a 16-Gy boost to a
standard 50-Gy treatment for breast cancer from the updated results of EORTC 22881 …

Purpose Little is known about reasons why eligible breast cancer patients decline BRCA
mutation testing. They may withdraw at different stages during genetic counseling for …

PURPOSE: To identify haplotypes of single nucleotide polymorphism markers associated
with the risk of early adverse skin reactions (EASRs) after radiotherapy in breast cancer …

Purpose REQUITE aimed to establish a resource for multi-national validation of models and
biomarkers that predict risk of late toxicity following radiotherapy. The purpose of this article …

Purpose: A minority of patients exhibits severe late normal tissue toxicity after radiotherapy
(RT), possibly related to their inherent individual radiation sensitivity. This study aimed to …

Background and purpose: The establishment of a predictive in vitro assay for radiosensitivity
has been a goal in radiotherapy research. To date, no single assay has proven to be …

Background: Gene expression assays are increasingly used for decision-making regarding
adjuvant chemotherapy in patients with hormone receptor-positive, HER2-negative breast …